Body dysmorphic disorder: often unseen yet demands clinical attention

Uncategorised
By
AP Staff
-

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th edn. Arlington, VA: American Psychiatric Association. 2013.
  2. Angelakis I, Gooding PA, Panagioti M. Suicidality in body dysmorphic disorder (BDD): a systematic review with meta-analysis. Clin Psychol Rev 2016;49:55–66.
  3. Marques L, LeBlanc N, Robinaugh D, et al. Correlates of quality of life and functional disability in individuals with body dysmorphic disorder. Psychosomatics 2011;52(3):245–54.
  4. Phillips KA, Menard W, Quinn E, et al. A 4-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder. Psychol Med 2013;43(5):1109–17.
  5. Veale D, Gledhill LJ, Christodoulou P, et al. Body dysmorphic disorder in different settings: a systematic review and estimated weighted prevalence. Body Image 2016;18:168–86.
  6. McGrath LR, Oey L, McDonald S, et al. Prevalence of body dysmorphic disorder: a systematic review and meta-analysis. Body Image 2023;46:202–11.
  7. Bartsch D. Prevalence of body dysmorphic disorder symptoms and associated clinical features among Australian university students. Clin Psychol 2007;11(1):16–23.
  8. Rück C, Mataix-Cols D, Feusner JD, et al. Body dysmorphic disorder. Nat Rev Dis Primers 2024;10(1):92.
  9. Longobardi C, Badenes-Ribera L, Fabris MA. Adverse childhood experiences and body dysmorphic symptoms: a meta-analysis. Body Image 2022;40:267–84.
  10. Walker DC. An experimental manipulation of body checking and mirror exposure over time in men and women with high shape or weight concern [dissertation]. Albany, NY: State University of New York at Albany. 2013.
  11. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry 2003;44(4):270–6.
  12. Atmaca M, Bingol I, Aydin A, et al. Brain morphology of patients with body dysmorphic disorder. J Affect Disord 2010;123(1–3):258–63.
  13. Rauch SL, Phillips KA, Segal E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res 2003;122(1):13–9.
  14. Buchanan B, Rossell S, Maller J, et al. Regional brain volumes in body dysmorphic disorder compared to controls. Aust N Z J Psychiatry 2014;48(7):654–62.
  15. Mohr HM, Röder C, Zimmermann J, et al. Body image distortions in bulimia nervosa: investigating body size overestimation and body size satisfaction by fMRI. Neuroimage 2011;56(3):1822–31.
  16. Vulink NCC, Planting R, Figee M, et al. Reduced striatal dopamine D2/3 receptor availability in body dysmorphic disorder. Eur Neuropsychopharmacol 2016;26(3):350–6.
  17. Fang A, Jacoby R, Beatty C, et al. Serum oxytocin levels are elevated in body dysmorphic disorder and related to severity of psychopathology. Psychoneuroendocrinology 2020;113:104523.
  18. Rossell SL, Castle DJ, Pikoos T, et al. Body dysmorphic disorder and the ugly truth of Australian healthcare. Aust N Z J Psychiatry 2023;57(11):1407–9.
  19. Schmidt M, Schoenenberg K, Engelkamp JE, et al. Efficacy of an internet-based, therapist-guided cognitive behavioral therapy intervention for adolescents and young adults with body dysmorphic disorder: a randomized controlled trial. BMC Psychiatry 2025;25(1):374.
  20. Frisira E, Tan SF, Partlett C, et al. Characteristics and 12-month outcomes of clinically-referred children and young people at risk of body dysmorphic disorder. Soc Psychiatry Psychiatr Epidemiol 2025. [Epub ahead of print]
  21. Flygare O, Chen L, Fernández de la Cruz L, et al. Empirically defining treatment response and remission in body dysmorphic disorder using a short self-report instrument. Behav Ther 2021;52(4):821–9.
  22. Castle DJ, Beilharz F, Phillips KA, et al. Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology. Int Clin Psychopharmacol 2021;36(2):61–75.
  23. Lynas K. Professionals you can trust: pharmacists top the list again in Ipsos Reid survey. Can Pharm J 2012;145(2):55.
  24. Buckley N, ed. Australian medicines handbook. 2026. At: https://amhonline.amh.net.au
  25. Suhas K, Royfmah A, King S, et al. SUN-820 the impact of GLP-1 agonists on the development of body dysmorphic disorder. J Endocr Soc 2025;9(Suppl 1):bvaf149.1325.